The use of antiretroviral therapy in human immunodeficiency virus type 1
Previous studies on HIV-1 latency were based on the generation of chronically infected cell lines, such as the ACH2 3 , JΔK 4 , and J-Lat 5 T-cell lines, and the U1 promonocytic cell line 6 . In these systems, latency was defined as a state in which integrated proviruses failed to elicit detectable gene expression.
However, these systems do not necessarily reflect the latency state in vivo because the lack of viral gene expression is due to mutations in tat (ACH2 and U1 3, 6 ) or mutations in the LTR (JΔK T-cell line 4 ). While these latency models recapitulate a plethora of mechanisms that can lead to viral latency, we were interested in developing a more general model that would not rely on clonal proviral integration sites, and which utilized non-transformed, primary human Tcells.
Recently, a model using human fetal liver tissue in SCID-hu mice has generated a great deal of interest in the field of HIV-1 latency , there are important differences between these cell types that would impact the establishment of latency and reactivation.
In the present study, we describe the development of a novel HIV-1 latency model that uses human, primary cells and we use this model to dissect relevant signaling pathways involved in viral reactivation from latently infected memory CD4
+ cells.
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Materials and Methods

Reagents
The following reagents were obtained through the AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, NIH: Human rIL-2 from Dr. Maurice Gately, Hoffman-La Roche Inc. 
T cells
Peripheral blood mononuclear cells were obtained from Leukopaks from unidentified, healthy donors. Naïve CD4+ T cells were isolated by MACS microbead negative sorting using the naïve T cell isolation kit (Milteny Biotec, Aurburn, CA). The purity of the sort population was always higher than 95% with a phenotype CD4 + CD45RA + CD45RO -CCR7 + CD62L + CD27 + .
Naïve T cells were primed with beads coated with anti-CD3 and anti-CD28
(Dynal/Invitrogen, Carlsbad, CA) as previously described 11 . Proliferating cells were expanded in medium containing 30 IU/ml IL-2, replacing media and IL-2 each 2 days. 
Virus generation and viral infection
Integration analysis
Genomic DNA from 10 6 was isolated with the DNeasy Tissue Kit (Quiagen, Valencia, CA). 250 ng of genomic DNA were subjected to quantitative Alu-LTR PCR for integrated provirus as previously described [14] [15] [16] .
Statistical Methods
Statistical analyses were performed with SPSS12. 
Results
A Novel Ex Vivo Paradigm to Study HIV-1 Latency
In order to recapitulate the generation of memory cell ex vivo, we isolated human, primary naïve CD4 + T cells using negative selection (Miltenyi Biotec, Auburn, CA; Figure 1 ). We then primed the naïve cells toward differentiation into non-polarized (NP), T helper-1 (Th1) or T helper-2 (Th2) as previously described 11 .
Phenotypic analysis confirmed the nature of the populations obtained in vitro ( Figure S1 ). In vivo, memory CD4 + T cells fall into two main categories, central memory (T CM ) and effector memory (T EM ). The transcriptional profile of in vivo T CM closely resembles that of in vitro T cells stimulated in NP conditions 11, 17 .
Specifically, both T CM and NP cells are characterized by simultaneous expression of CCR7 (a homing receptor for secondary lymphoid tissues) and CD27 (a coactivation molecule) 11, 17 . Expression of CCR7 and CD27 is also found on naïve cells, but is absent in T EM . We analyzed the expression of CCR7 and CD27
in the cells at 0 (naïve), 7, 14 and 21 days after initial activation ( Figure S1 ). As expected, naïve CD4 + T cells expressed high levels of CCR7 and CD27, as did cells primed in NP conditions. In contrast to NP, priming under Th1-and Th2-polarizing conditions led to loss of CCR7 and CD27 expression, and generated populations with phenotypes that were characteristic of both T EM cells and T CM cells ( Figure S1 ).
At day 7, cells from NP, Th1 and Th2 conditions were exposed to virus. A unique aspect of the model presented here is that the virus used in this model, In order to induce reactivation of potential latent viruses, at day 7 p.i., cells were restimulated for 3 days in the presence of beads coated with αCD3 and αCD28 antibodies ( Figure 2C , CD3/CD28). As a negative control, we incubated parallel cultures in the absence beads ( Figure 2C , untreated). We detected low levels of p24
Gag+ cells in the absence of restimulation ( Figure 2C , upper panels).
However, restimulation led to an increase in the percentage of p24 Gag+ cells in all subsets ( Figure 2C , lower panels). Remarkably, levels of p24 Gag+ cells after reactivation were higher in NP cells than in Th1 or Th2.
The results shown in Figure 2C correspond to a single blood donor (Donor 1). To verify the generality of these findings in a broader population, we performed further experiments with 6 additional donors. The results, summarized in Figure 2D , and confirm that NP cells and, to a lesser degree, Th2-polarized cells, can harbor high levels of HIV-1 latency, whereas Th1-polarized cells displayed low levels of latency.
To evaluate the levels of viral infection by a method that would be independent of viral gene expression we resorted to quantitative Alu-PCR [14] [15] [16] .
Quantitative Alu-PCR is specific for integrated viral DNA and should detect latent and productive infections with the equal efficiency. We performed Alu-PCR at Alu-PCR that were roughly equivalent or higher ( Figure 2E ) than those seen in Th2 or NP. Therefore, it appears that Th1 cells are able to sustain higher levels of initial productive infection (i.e., p24 Gag+ ; Figure 2A , day 5 p.i), followed by higher levels of apoptotic death, leading to less frequent latent infections.
Detection of viral gene expression can also be accomplished via reporter molecules, such as GFP, with high sensitivity and specificity 5 . To test whether our latency and reactivation system would produce similar results when using GFP as a reporter, we performed parallel infections with DHIV/X4 and DHIV-GFP/X4 ( Figure S2 ). In DHIV-GFP, nef had been replaced by the enhanced green fluorescent protein gene One of the proximal events after activation of T cells through CD3 and CD28 is activation of the tyrosine kinase, Lck (see Figure S3 ) (for a review, see phosphorylation and degradation of IκB, with the subsequent release and nuclear translocation of the transcription factor, NFκB 23 . We probed the DAG-PKC-NFκB signaling axis by restimulating cells in the presence or absence of the general PKC inhibitor, BIM; we also tested an inhibitor of the classic isoforms of PKC (α, β and γ), Gö6976; or Rottlerin, a specific inhibitor of PKCθ. None of these three compounds had a negative effect on viral reactivation ( Figure 3A) . To confirm the previous result, we used IκB kinase peptide inhibitor (IKK inh) 24 . When cells were reactivated in the presence of IKK inh, the levels of viral reactivation were not affected.
DAG activates also Ras guanyl-nulceotide-releasing protein (RasGRP) 25 .
RasGRP and many isoforms of PKC activate Ras, leading to subsequent activation of the mitogen-activated protein (MAP) kinases, Erk1/2 (MEK), JNK, and p38. To probe the DAG-Ras-MAPK axis, we resorted to inhibition of JNK or Erk1/2 with SP600125 or PD98059, respectively. Neither SP600125 nor PD98059 inhibited viral reactivation. In contrast, an inhibitor of p38, SB202190, significantly diminished (66% inhibition; Figure 3A ) HIV-1 reactivation.
The other second messenger generated by PLCγ1, IP3, activates calcineurin, which dephosphorylates and activates the transcription factor, NFAT To complement the inhibitor studies, we undertook additional experimentation using agonists for the above signaling pathways. Latently infected cells were either left untreated or incubated with agonist. As a positive control, cells were treated with αCD3/CD28. The ability of the agonist to promote viral reactivation was then evaluated by detection of intracellular p24
Gag as shown above (Figure 4 ). We first tested phytohemagglutinin (PHA), a lectin that binds non-specifically to carbohydrate moieties on surface glycoproteins and acts To activate the DAG-PKC-NFκB signaling axis, we used PMA and, separately, prostratin (both direct activators of PKC). Neither compound was able to reactivate viral gene expression ( Figure 4A ).
Signaling downstream of IP3 involves an increase in intracellular levels of calcium. To directly stimulate calcium influx, we incubated cells with Ionomycine, and this had no effect on viral reactivation. However, combination of PMA and Ionomycine was able to induce minor, but significant, levels of reactivation (4%).
In agreement with the lack of effect of H-89 (an inhibitor of PKA; Figure   3A ), incubation of cells with the PKA activator, forskolin, failed to reactivate virus gene expression.
In tumor cell lines harboring integrated, latent HIV-1 TNF-α can induce viral gene expression through the activation of NFκB 3, 5, 28, 29 . We tested the potential role of TNF-α in virus reactivation in latently infected memory T cells. We found that TNF-α failed to induce any degree of viral gene expression ( Figure   4A ).
Inhibition of histone deacetylases (HDAC) with valproic acid (VA) has
previously been shown to induce viral reactivation [30] [31] [32] . In our latent infection system, however, incubation with VA failed to reactivate viral gene expression ( Figure 4A ).
As with the inhibitor studies, results with signaling pathway agonists were very similar in three different donors (Donors 1, 3 and 4), as shown in Figure 4B .
From the above studies, we conclude that optimal HIV-1 reactivation in memory T cells requires a pathway that includes, upstream, the tyrosine kinase, Lck, and, downstream, the transcription factor, NFAT.
LTR sites required for HIV-1 reactivation.
The HIV-1 latency model we present here uses molecularly cloned virus and recapitulates a single virus replication cycle. Therefore, this system should allow us to ask which transcription factor binding sites in the viral promoter may be required for efficient reactivation. To that end, we engineered the DHIV viral construct to contain mutations in specific regions known to regulate LTR-driven transcription [33] [34] [35] [36] [37] [38] [39] . These mutations were engineered in the U3 region of the 3' LTR, such that the mutant promoter would be copied into the 5' end of the virus after the first round of reverse transcription. We constructed mutants in the regions showed in Figure 5A (See also the specific mutations in Figure 4S ). NP cells were infected with mutant-promoter viruses, and cells were kept in vitro for Figure 5B) , to asses the levels of latent infection prior to reactivation.
We then restimulated the cells with αCD3/CD28 and analyzed intracellular p24
Gag expression 3 days later.
As shown in Figure 5B , mutation in the Sp1 sites abolished any ability of latent viruses to be reactivated (0.3%; efficiency of reactivation = ([p24% of mutant with αCD3/CD28 -p24% of mutant without αCD3/CD28]/[p24% of wtvirus with αCD3/CD28 -p24% of wt-virus without αCD3/CD28] X 100). Likewise, mutation of both κB/NFAT sites almost completely abolished reactivation (9.5%).
Mutation of the AP-2 binding site led to a reactivation efficiency of 64%. Mutation of both NF-IL6 I and NF-IL6 II binding sites, USF or TCF-1α had almost no effect (equal or higher than 85% reactivation efficiency).
The viral mutagenesis results together with the inhibitor and agonist studies indicate that the transcription factors, NFAT and Sp1 are essential for reactivation in human NP memory CD4 T cells. Further dissection of signaling pathways and requirements for latency and reactivation can easily be pursued in the future, using this ex vivo system.
For personal use only. on August 31, 2017. by guest www.bloodjournal.org From Discussion HIV-1 latency reservoirs are small, but extremely long-lived. Latent infection is associated with low-to-null levels of viral gene expression and appears to be non-cytopathic. However, upon reactivation, latent viruses enter an active mode of replication in which they are fully competent for spread and induction of disease. The current thinking in the field is that the combination of hypothetical drugs that will re-activate latent viruses, in combination with presentday antiretroviral drugs, is the desired approach toward viral eradication.
However, we are limited by the scarcity of known drugs that can safely be used for viral reactivation. We are also limited by our poor understanding of the dynamics between establishment of latency and reactivation, and the cellular and viral factors that govern these processes. Our work describes the development of a novel method that recapitulates latent and productive viral infections in the laboratory. This method is easy to perform, powerful, and, most importantly, lends itself to molecular analysis.
One key question about HIV-1 latency is what specific cell type(s) can harbor long-lived, latent proviruses. Previous work by several groups (reviewed in 40, 41 ) suggests that in vivo, quiescent memory T-cells constitute the most longlived viral reservoir, whose decay constant ranges from months to years. Memory cells, in vivo, are subdivided into various subsets whose biology can faithfully be recapitulated in vitro 11 . We tested the relative abilities of NP, Th1 and Th2 cells to harbor latent viruses and found that, while latent infections could be induced in all subsets, NP were consistently more permissive for latent infection and For personal use only. on August 31, 2017. by guest www.bloodjournal.org From accordingly less able to sustain productive infection. Conversely, Th1 cells were exquisitely sensitive to productive infection, and latent infection of these cells was significantly lower. It is tempting to speculate that the higher permissiveness to productive infection of Th1 cells was the cause of enhanced levels of apoptosis.
A unique aspect of the method presented here is that the virus is defective in Env. When the virus is produced, Env is provided in trans. Thus, upon infection, viral particles contain the full protein complement of HIV-1, and are fully infectious and competent for entry, reverse transcription, integration, and viral gene expression. However, the engineered defect in Env precludes the production of infectious progeny. Cells undergoing productive infection die within 3-5 days due to virus-mediated apoptosis and only uninfected and latently infected cells survive after the first week in culture.
A second unique feature of this system is the intrinsic ability of the virus to drive wild-type levels of gene expression. This is a crucial aspect of our model, as latent viruses in vivo, when reactivated, are fully capable of replicating and causing disease. This is an important distinction with previous models of latency in which lack of viral gene expression was shown to be associated with mutations in the virus or in the host cell 29, [42] [43] [44] [45] or with specific sites of virus integration in heterochromatin 5 .
HIV-1 latency appears to be related to intrinsic activation and/or development characteristics of CD4 + T cells, rather than to the presence of latency-promoting genes in the virus. Thus, it is important to dissect, at a molecular level, the T-cell signaling pathway(s) that underlie the establishment, For personal use only. on August 31, 2017. by guest www.bloodjournal.org From maintenance, and reactivation of latent infections. In the present work, we used a three-prong approach to dissect signaling events leading to reactivation in primary memory cells. We used agonists and antagonists of cellular processes, and mutagenesis of viral cis acting elements. The Sp1 and κB/NFAT promoter elements were critical toward reactivation.
Although Sp1 has been considered a ubiquitous and constitutive transcription factor, an emerging body of evidence indicates that the activity of Sp1 is regulated through the cell cycle 46, 47 . Sp1 is phosphorylated and inactive in quiescent cells. Upon entry into the cell division cycle, PP2A dephosphorylates Sp1, which becomes active and tightly associated with the chromatin 46, 47 . Our finding that Sp1 is absolutely required for reactivation of latent HIV-1 is in agreement with the idea that a latently infected cell in vivo may be quiescent, and reactivation of the virus is concomitant with entry into the cell division cycle.
The κB/NFAT binding sites, also a stringent requirement for viral reactivation, are not separable by mutagenesis because NFκB and NFAT bind identical elements on the LTR 48 . The potential roles played by NFAT and NFκB in reactivation are of paramount importance in our studies, as it has recently been shown that naïve cells contain very low levels of NFATc1 and NFATc2, whereas memory cells contain high levels of such transcription factors 49 . This explains why both naïve and memory T cells rapidly induce IL-2 (whose promoter contains a κB/NFAT binding site) transcription upon T cell receptor ligation, but the responsible transcription factors differ, being NFκB for naïve cells, and NFAT for memory cells 49 . Therefore, one would predict that in memory cells NFAT, but
For personal use only. on . by guest www.bloodjournal.org From not NFκB, would be essential for viral reactivation. The results from our inhibitor studies clearly confirm this prediction, as CsA incubation completely blocked reactivation whereas IKK Inh or PKC inhibitors had no effect. In further support for the lack of a role of NFκB in viral reactivation in memory cells, agonists or stimuli that function through NFκB, such as PMA, prostratin and TNF-α, failed to induce any degree of reactivation.
We tested two agonists of NFAT activation, PHA and Ionomycin. It is intriguing that PHA induced reactivation almost as efficiently as αCD3/CD28 treatment, while Ionomycin produced no detectable reactivation. PHA is a promiscuous mitogen that activates multiple pathways. However the observation that addition of CsA or PP2 completely blocked reactivation by PHA further supports that the required signaling axis dowstream of PHA is Lck-Calcineurin-NFAT. In this context, the failure of Ionomycin to induce reactivation was surprising, and could underlie important mechanistic details. Two possible explanations could be formulated. First, Ionomycin alone is unable to induce cell proliferation. In the absence of cell proliferation, Sp1 would fail to be dephosphorylated and activated 46, 47 , as we discussed above. In partial support of this idea is, perhaps, the observation that addition of PMA to Ionomycin treatment did stimulate reactivation, albeit to a small degree, concomitant with cell proliferation (data not shown). A second possible explanation is that both αCD3/CD28 and PHA induce activation of calcineurin (see Figure 3S) Inhibition of p38 with SB202190 had a significant effect (66% inhibition) on viral reactivation. p38 participates in two signaling events that may be relevant to viral reactivation ( Figure 3S ). The classical p38 activation pathway requires signaling through DAG-RasGRP/PKC-Ras, whose inhibition did not affect reactivation. In recent years, an alternative p38 activation pathway has been described, which utilizes a scaffold protein known as Dlgh1
50
. Dlgh1 is devoid of any known enzymatic activity, but can modify the signaling emerging from TCR engagement, transmitted through ZAP70 and Lck, to facilitate p38 activation and subsequent activation of NFAT in a calcineurin-dependent manner (see Figure   3S ). Likely, this alternative pathway 50 is the target the of p38 inhibition on viral reactivation. Further experimentation will be required to confirm this model.
Our results are similar, although with important differences, to those reported earlier using a SCID-hu mouse model of HIV-1 latency 
